{"id":45305,"date":"2022-06-21T15:01:31","date_gmt":"2022-06-21T13:01:31","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/uspi-and-united-urology-group-to-form-joint-venture\/"},"modified":"2022-06-21T15:01:31","modified_gmt":"2022-06-21T13:01:31","slug":"uspi-and-united-urology-group-to-form-joint-venture","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/uspi-and-united-urology-group-to-form-joint-venture\/","title":{"rendered":"USPI and United Urology Group to Form Joint Venture"},"content":{"rendered":"
\n

DALLAS & OWINGS MILLS, Md.–(BUSINESS WIRE)–United Surgical Partners International (USPI), the largest ambulatory platform in the country and a subsidiary of Tenet Healthcare (NYSE: THC), and United Urology Group (UUG), one of the nation\u2019s largest networks of urology affiliate practices, today signed a definitive agreement to form a joint venture partnership in 22 ambulatory surgery centers (ASCs). USPI will acquire a portion of UUG\u2019s ownership interests in well-established and brand-new facilities located in Maryland, Colorado and Arizona.\n<\/p>\n

\nA partnership with USPI will help UUG and its affiliated practices accelerate the delivery of ASCs in new markets and make patient care more accessible. The addition of UUG and its affiliated practice ASCs will complement USPI\u2019s growing urology service line and expand its partnership network with more than 140 leading urology physicians.\n<\/p>\n

\n\u201cUnited Urology Group\u2019s premier affiliated practices have set a very high standard for exemplary urologic care,\u201d said Brett Brodnax, President and CEO of USPI. \u201cThe partnership will add high-quality urology centers within our existing markets. We are honored to serve additional patients and support the growth of these ASCs.\u201d\n<\/p>\n

\n\u201cUSPI\u2019s commitment to innovation and depth of operational knowledge will benefit the growth and development of our ASCs,\u201d said Sanford J. Siegel, MD, CEO of United Urology Group. \u201cWe have an exciting runway with USPI as our partner and look forward to bringing our patient-focused cultures together.\u201d\n<\/p>\n

\nThe transaction is expected to be completed in the third quarter, subject to regulatory approvals and closing conditions. Upon completion, USPI will manage and jointly own the centers with UUG and its affiliated practices. The centers will be consolidated in Tenet Healthcare\u2019s financial statements.\n<\/p>\n

\nAbout USPI<\/i><\/b>\n<\/p>\n

\nUnited Surgical Partners International (USPI), a subsidiary of Tenet Healthcare Corporation (NYSE: THC), operates the largest ambulatory platform in the country. With more than 440 facilities across the United States, the company serves patients in ambulatory surgery centers and surgical hospitals. For more information, please visit www.uspi.com<\/a>.<\/i>\n<\/p>\n

\nAbout United Urology Group<\/i><\/b>\n<\/p>\n

\nUnited Urology Group (UUG) is one of the nation\u2019s <\/i>largest networks of urology affiliate practices<\/i> whose affiliates include: Arizona Urology Specialists with offices in the greater Phoenix\/Scottsdale and Tucson areas; Chesapeake Urology, with offices located throughout Maryland and Delaware; Tennessee Urology, based in the greater Knoxville area and Eastern Tennessee; and Colorado Urology, located in the greater Denver and Front Range areas. UUG and affiliate practice staff number more than 1,400 employees, including 220+ physicians and advanced practice providers, in five states. UUG\u2019s vision is to lead the transformation of urology through its commitment to accessible, high quality, and value-based care; patient and employee satisfaction; preserving autonomy of affiliate practices; continuous innovation; and community involvement.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor USPI<\/i>
<\/b>Lesley Bogdanow
\n
469-893-2640
\n
communications@uspi.com<\/a>\n<\/p>\n

\nFor UUG<\/i>
<\/b>Severa Lynch
\n
833-595-2500
\n
slynch@uniteduro.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DALLAS & OWINGS MILLS, Md.–(BUSINESS WIRE)–United Surgical Partners International (USPI), the largest ambulatory platform in the country and a subsidiary of Tenet Healthcare (NYSE: THC), and United Urology Group (UUG), one of the nation\u2019s largest networks of urology affiliate practices, today signed a definitive agreement to form a joint venture partnership in 22 ambulatory surgery … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45305","6":"format-standard","7":"category-industry"},"yoast_head":"\nUSPI and United Urology Group to Form Joint Venture - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/uspi-and-united-urology-group-to-form-joint-venture\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"USPI and United Urology Group to Form Joint Venture - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DALLAS & OWINGS MILLS, Md.–(BUSINESS WIRE)–United Surgical Partners International (USPI), the largest ambulatory platform in the country and a subsidiary of Tenet Healthcare (NYSE: THC), and United Urology Group (UUG), one of the nation\u2019s largest networks of urology affiliate practices, today signed a definitive agreement to form a joint venture partnership in 22 ambulatory surgery ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/uspi-and-united-urology-group-to-form-joint-venture\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-21T13:01:31+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspi-and-united-urology-group-to-form-joint-venture\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspi-and-united-urology-group-to-form-joint-venture\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"USPI and United Urology Group to Form Joint Venture\",\"datePublished\":\"2022-06-21T13:01:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspi-and-united-urology-group-to-form-joint-venture\\\/\"},\"wordCount\":475,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspi-and-united-urology-group-to-form-joint-venture\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspi-and-united-urology-group-to-form-joint-venture\\\/\",\"name\":\"USPI and United Urology Group to Form Joint Venture - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-06-21T13:01:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspi-and-united-urology-group-to-form-joint-venture\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspi-and-united-urology-group-to-form-joint-venture\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/uspi-and-united-urology-group-to-form-joint-venture\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"USPI and United Urology Group to Form Joint Venture\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"USPI and United Urology Group to Form Joint Venture - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/uspi-and-united-urology-group-to-form-joint-venture\/","og_locale":"en_US","og_type":"article","og_title":"USPI and United Urology Group to Form Joint Venture - Pharma Trend","og_description":"DALLAS & OWINGS MILLS, Md.–(BUSINESS WIRE)–United Surgical Partners International (USPI), the largest ambulatory platform in the country and a subsidiary of Tenet Healthcare (NYSE: THC), and United Urology Group (UUG), one of the nation\u2019s largest networks of urology affiliate practices, today signed a definitive agreement to form a joint venture partnership in 22 ambulatory surgery ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/uspi-and-united-urology-group-to-form-joint-venture\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-21T13:01:31+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/uspi-and-united-urology-group-to-form-joint-venture\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/uspi-and-united-urology-group-to-form-joint-venture\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"USPI and United Urology Group to Form Joint Venture","datePublished":"2022-06-21T13:01:31+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/uspi-and-united-urology-group-to-form-joint-venture\/"},"wordCount":475,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/uspi-and-united-urology-group-to-form-joint-venture\/","url":"https:\/\/pharma-trend.com\/en\/uspi-and-united-urology-group-to-form-joint-venture\/","name":"USPI and United Urology Group to Form Joint Venture - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-06-21T13:01:31+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/uspi-and-united-urology-group-to-form-joint-venture\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/uspi-and-united-urology-group-to-form-joint-venture\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/uspi-and-united-urology-group-to-form-joint-venture\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"USPI and United Urology Group to Form Joint Venture"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45305","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45305"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45305\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45305"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45305"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}